ARTHUR-D.-LITTLE
10.9.2019 19:02:09 CEST | Business Wire | Press release
Arthur D. Little, AT&T, Deutsche Telekom and Telefónica today released a major new study outlining the vital importance of the telecoms industry moving to a more virtualized, converged and cloud-based architecture for its access networks. This will enable it to meet three current challenges - demand growing faster than revenues, technology convergence and the increasing value delivered by third parties within their ecosystems.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190910005879/en/
Based on their experience and expertise, the Who Dares Wins! report argues that operators need to move to modular Central Office pod (“CO pod”) architectures, replacing traditional access network technologies. This cloud-based approach disaggregates proprietary equipment into general-purpose hardware and reproduces the relevant functions in software managed by standard IT automation tools. This increases efficiency, widens up the range of equipment suppliers, enables greater innovation and allows greater convergence.
The report argues that the new CO pod architecture can be used to catapult the telecom fixed and mobile access industry production model into a cloud-like future. Moreover, the architecture provides a safe place for each operator to innovate and explore new services, and, going at their own pace, to transform skills, operations, and business processes to benefit from improved agility.
However, the report recognizes that there is still more work to be done. Telecom ecosystems are not yet on a par with IT and web scale data centers, so the industry must work together as a community, in order to move into the future.
Tom Anschutz, Distinguished Member of Technical Staff at AT&T says: “AT&T is trailblazing automation and cloudification, but a trail is not for a single traveler - we realize the strong benefits of working toward these goals with open community collaboration. I hope that this paper attracts more like-minded companies to participate with us.”
Dr. Hans-Jörg Kolbe , Head of Deutsche Telekom’s Access 4.0 DevOps organization notes: “It is important for us to further develop the disaggregated Central Office and cloud technology to broaden our partner community, in order to attract the best technology and thinking into building our future networks based on the Access 4.0 design.”
David del Val, Director of Core Innovation at Telefónica states: “The Who Dares Wins! study leverages our learnings and provides useful references to support the sector in addressing common challenges in its quest to create an environment that can accelerate the creation of new services and revenues.”
Salman Ali, Principal at Arthur D. Little concludes: “More than ever, the challenges facing the industry require fresh thinking. In order to stay competitive in the short term and remain relevant in the long term, the industry must differentiate itself and drive innovation. To achieve this, operators should build new capabilities and regenerate their ecosystems through step out approaches like the Central Office pod architecture.”
Through the report, the joint team has openly shared their current thinking, details of what they are doing and how they have organized their operations around CO pod architectures. The aim is to encourage wider debate and adoption of the concept at both a business and technology level. The team also stresses that the timing is right to move to this new model, given greater focus on convergence and the impending deployment of FTTx and 5G.
To download the full report, visit: www.adl.com/whodareswins
About Arthur D. Little
Arthur D. Little has been at the forefront of innovation since 1886. We are an acknowledged thought leader in linking strategy, innovation and transformation in technology-intensive and converging industries. We navigate our clients through changing business ecosystems to uncover new growth opportunities. We enable our clients to build innovation capabilities and transform their organizations.
Our consultants have strong practical industry experience combined with excellent knowledge of key trends and dynamics. Arthur D. Little is present in the most important business centers around the world. We are proud to serve most of the Fortune 1000 companies, in addition to other leading firms and public sector organizations.
For further information, please visit www.adlittle.com .
About AT&T Communications
We help family, friends and neighbors connect in meaningful ways every day. From the first phone call 140+ years ago to mobile video streaming, we innovate to improve lives. We have the nation’s fastest wireless network.** And according to America’s biggest test, we have the nation’s best wireless network.*** We’re building FirstNet just for first responders and creating next-generation mobile 5G. With a range of TV and video products, we deliver entertainment people love to talk about. Our smart, highly secure solutions serve nearly 3 million global businesses – nearly all of the Fortune 1000. And worldwide, our spirit of service drives employees to give back to their communities.
AT&T Communications is part of AT&T Inc. (NYSE:T ). Learn more at att.com/CommunicationsNews .
AT&T products and services are provided or offered by subsidiaries and affiliates of AT&T Inc. under the AT&T brand and not by AT&T Inc. Additional information about AT&T products and services is available at about.att.com . Follow our news on Twitter at @ATT, on Facebook at facebook.com/att and on YouTube at youtube.com/att .
© 2019 AT&T Intellectual Property. All rights reserved. AT&T, the Globe logo and other marks are trademarks and service marks of AT&T Intellectual Property and/or AT&T affiliated companies. All other marks contained herein are the property of their respective owners.
**Based on analysis by Ookla® of Speedtest Intelligence® data average download speeds for Q2 2019.
***GWS OneScore, September 2019.
Deutsche Telekom
Deutsche Telekom is one of the world's leading integrated telecommunications companies, with some 178 million mobile customers, 28 million fixed-network lines, and 20 million broadband lines, across more than 50 countries. With a staff of some 216,000 employees throughout the world, Deutsche Telekom generated revenue of 75,7 billion Euros in the 2018 financial year.
For further information, please visit www.telekom.com .
Telefónica
Telefónica is one of the largest telecommunications companies in the world by market capitalization and number of customers, with a comprehensive offering of world-class fixed, mobile and broadband connectivity services. The company has a significant presence in 21 countries, with strong presence in Spain, Europe and Latin America. In 2017 Telefónica had consolidated revenues of 52 billion euros, consisting of 272 million mobile phone subscribers, 21.4 million Internet and data lines, and 8.5 million pay-TV customers. Telefónica is a 100 percent listed company, with more than 1.5 million direct shareholders. Its shares are traded on the Spanish Stock Market and on those in London, New York, Lima, and Buenos Aires.
For further information, please visit www.telefonica.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20190910005879/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
IMPACT Therapeutics and Pharmanovia Announce Positive CHMP Opinion for Senaparib, as a Potential First-Line Maintenance Treatment of Advanced High-Grade Epithelial Ovarian, Fallopian Tube, and Primary Peritoneal Cancer18.9.2026 12:38:00 CEST | Press release
For business and medical media only This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918325771/en/ Stephan Eder, CEO, Pharmanovia IMPACT Therapeutics (07630.HK), a commercial-stage biotechnology company focused on the discovery and development of targeted anti-cancer therapeutics based on synthetic lethality mechanisms, together with global specialty pharmaceutical company Pharmanovia, today jointly announce that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the granting of a Marketing Authorisation (MA) for the medicinal product Sepalna® (senaparib) intended for the maintenance treatment of advance epithelial ovarian, fallopian tube and primary peritoneal cancer. Following the CHMP’s recommendation for approval, senaparib will be submitted to the European Commission (EC) for final decision. Once approved by the EC, senaparib will
Estithmar Holding Announces Completion of 48.68% Stake Transfer in Shahba Bank to Masaref Holding, a Subsidiary of Estithmar Capital18.9.2026 11:48:00 CEST | Press release
Estithmar Holding Q.P.S.C. announced the completion of the transfer of a 48.68% stake in Shahba Bank to Masaref Holding LLC, subsidiary of Estithmar Capital, Estithmar Holding’s financial services and investments arm. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918807909/en/ Estithmar Holding Announces Completion of 48.68% Stake Transfer in Shahba Bank to Masaref Holding, a Subsidiary of Estithmar Capital (Photo: AETOSWire) As a shareholder, Masaref Holding intends to support the assessment of proposals aimed at strengthening Shahba Bank’s financial, operational and technological capabilities, including potential capital enhancement, branch network expansion, and the development of products and services for individuals, businesses and SMEs. The proposals may include modernizing banking and operational systems, develop digital services, and strengthen governance, compliance, risk management and cybersecurity to enhance
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
